	Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy. Sci Rep Elkramani N, Elzallat M, Mohammed DM, AbdelLatif A, Aboushousha T, El-Ahwany E. PMID: 42106389 [PubMed - indexed for MEDLINE]
	Microwave Ablation with or without TACE for Unresectable Large Hepatocellular Carcinoma: Impact of Tumor Burden Score on Efficacy. J Gastrointest Cancer Wang Z, Wang Z, Li J, Li L, Wang S, Liu F, Yu J, Liang P, Yu X. PMID: 42105132 [PubMed - indexed for MEDLINE]
	Development of a machine learning-based prognostic prediction model and a web-based tool for pediatric hepatoblastoma: a Surveillance, Epidemiology, and End Results (SEER) database study. Pediatr Surg Int Chen Z, Wei Y, Liu S, Zhang J. PMID: 42105007 [PubMed - indexed for MEDLINE]
	TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study. Front Immunol Su Y, Liang Y, Zhong D, Chen Y, Wang M, Yang Q, Yan H, Huang X. PMID: 42099657 [PubMed - indexed for MEDLINE]
	Current progress and emerging trends of car-based immunotherapy for hepatocellular carcinoma: a data-driven atlas from multidatabase integration. Front Immunol Ying H, Pan Y, Zhu X, Xuan Q. PMID: 42099608 [PubMed - indexed for MEDLINE]
	Inflammation in hepatocellular carcinoma progression: a "Single Wick, dual interwoven strands" regulatory framework. Front Immunol Wu C, Dong J, Sui S, Tan X, Zhu N. PMID: 42099598 [PubMed - indexed for MEDLINE]
	Analysis of colorectal liver metastases in photon-counting detector CT - optimizing imaging through spectral reconstruction. Cancer Imaging Moos M, Emrich T, Nguyen M, Steinmetz S, Kloeckner R, Hahn F, Steiner P, Scholz C, Moehler M, Lang H, Bäuerle T, Jorg T, Müller L. PMID: 42098885 [PubMed - indexed for MEDLINE]
	Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. PLoS One Nishioka C, Tahata Y, Maesaka K, Kai M, Shirai K, Murai K, Makino Y, Saito Y, Nozaki Y, Nakabori T, Ishida H, Yakushijin T, Iio S, Tatsumi N, Imanaka K, Kakita N, Sakamori R, Hosui A, Miyazaki M, Matsumoto K, Nakahara M, Doi Y, Sakakibara M, Hikita H, Kodama T, Takehara T. PMID: 42096473 [PubMed - indexed for MEDLINE]
	Local and systemic cytokine signatures for outcome prediction after transarterial chemoembolization in hepatocellular carcinoma. Theranostics Yilmaz EY, Schmidt R, Heidemann L, He Y, Liu Y, Sulejmani O, Müller DN, Wilhelm A, Auer TA, Hamm CA, Abosabie SAS, Abosabie SA, Gebauer B, Savic LJ. PMID: 42094598 [PubMed - indexed for MEDLINE]
	Fenugreek seed extract-doxorubicin synergy against hepatocellular carcinoma in HepG2 cells: in vitro and in silico mechanistic studies. BMC Complement Med Ther Ragab W, Mahmoud K, Allam RM, Qayed WS, Gomaa OM, El-Hawary SS, Moawad AS, Mohammed R. PMID: 42092913 [PubMed - indexed for MEDLINE]
	Sintilimab (PD-1 inhibitor) plus lenvatinib as conversion therapy followed by sequential surgery (SILENSES) for advanced unresectable hepatocellular carcinoma: a phase II, expansion trial. Signal Transduct Target Ther Lu S, Zhang W, Li J, Zhang Z, Hu B, Li X, Cao Y, Wang Z, Wang Z, Ye H, Qu B, Li Y, Ma G, Wan T, Liu Z, Liu B, Xu Y, Tang H, Zhao X, Pan L, Yang L, Yuan J, Chen R, Bian X. PMID: 42091859 [PubMed - indexed for MEDLINE]
	Nutritional Risk Assessed by Royal Free Hospital-Nutritional Prioritizing Tool Predicts Survival in Cirrhosis With or Without Hepatocellular Carcinoma. J Korean Med Sci Park HJ, Jung JK, Noh J, Kim Y, Lee SU, Yun BC, Lee JW, Kim HJ, Seo KI. PMID: 42089136 [PubMed - indexed for MEDLINE]
	Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era. BMJ Open Gastroenterol Chen S, Shen L, Qi H, Hu P, Cao F, Xie L, Wang Y, Fan W. PMID: 42086291 [PubMed - indexed for MEDLINE]
	Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma. Radiology Berman ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, Sandow T, Gimenez J, Young S, Fidelman N, Pianka KT, Sher A, Alamuri T, Chan SM, Vakil P, Wang M, Abounorinejad F, Som A, Johnson GE, Padia SA, Kim E, Toskich BB. PMID: 42084516 [PubMed - indexed for MEDLINE]
	Diffusion-weighted Imaging of the Liver: Primed for New Business. Radiology Brunsing RL, Syed AB, Hargreaves BA, Ennis DB. PMID: 42084512 [PubMed - indexed for MEDLINE]
	Risk of Intrahepatic and Extrahepatic Cancers in HepatitisÂ C Virus Infection: A Nationwide Cohort Study in Korea, 2005-2023. Liver Int Park Y, Kim BW, Oh JK, Kim BH, Park SJ, Kim KA, Ki M. PMID: 42084000 [PubMed - indexed for MEDLINE]
	Identification of CD4+ T Cell-Related Biomarkers and Mechanisms for Hepatoma. Comb Chem High Throughput Screen Zhang Z, Guo L, Luo J, Zheng J, Zeng H. PMID: 42083412 [PubMed - as supplied by publisher]
	Tri-Scenario-Based MAICOHAN Strategy for Minimally Invasive Extended Left Hepatectomy. Asian J Endosc Surg Yamamoto Y, Morimura R, Imamura T, Kubo H, Shibata R, Inoue H, Kurashima K, Nishibeppu K, Nanishi K, Kiuchi J, Shimizu H, Arita T, Kosuga T, Konishi H, Fujiwara H, Shiozaki A. PMID: 42082340 [PubMed - indexed for MEDLINE]
	Blood protein biomarkers in hepatocellular carcinoma: progress and challenges. PeerJ Zhang L, Zhang M, Bao Y, Yang J, Luo T, Zhang Y, Wang Y, Liu P, Guo X. PMID: 42079726 [PubMed - indexed for MEDLINE]
	Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis. Front Immunol Zhang Q, Lei Z, Qing H, Xie X. PMID: 42079632 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76047

Page 1 of 3803



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy